AAAAAA

   
Results: 1-7 |
Results: 7
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
Authors: Spitzer, TR McAfee, S Sackstein, R Colby, C Multani, P Saidman, S Weymouth, D Preffer, F Poliquin, C Foley, A Cox, B Andrews, D Sachs, DH Sykes, M
Citation: Tr. Spitzer et al., Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies, BIOL BLOOD, 6(3A), 2000, pp. 309-320
Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates
Authors: Kawai, T Wee, SL Bazin, H Latinne, D Phelan, J Boskovic, S Ko, DSC Hong, HZ Mauiyyedi, S Nadazdin, O Abrahamian, G Preffer, F Colvin, RB Sachs, DH Cosimi, AB
Citation: T. Kawai et al., Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates, TRANSPLANT, 70(2), 2000, pp. 368-374
Accessory cells with immunophenotypic and functional features of monocyte-derived dendritic cells are recruited to the lung during pulmonary inflammation
Authors: Tager, AM Luster, AD Leary, CP Sakamoto, H Zhao, LH Preffer, F Kradin, RL
Citation: Am. Tager et al., Accessory cells with immunophenotypic and functional features of monocyte-derived dendritic cells are recruited to the lung during pulmonary inflammation, J LEUK BIOL, 66(6), 1999, pp. 901-908
Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects afternon-myeloablative therapy and HLA-mismatched bone-marrow transplantation
Authors: Sykes, M Preffer, F McAfee, S Saidman, SL Weymouth, D Andrews, DM Colby, C Sackstein, R Sachs, DH Spitzer, TR
Citation: M. Sykes et al., Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects afternon-myeloablative therapy and HLA-mismatched bone-marrow transplantation, LANCET, 353(9166), 1999, pp. 1755-1759
The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model
Authors: Dey, B Yang, YG Preffer, F Shimizu, A Swenson, K Dombkowski, D Sykes, M
Citation: B. Dey et al., The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model, TRANSPLANT, 68(1), 1999, pp. 141-149
In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients
Authors: Vallhonrat, H Williams, WW Cosimi, AB Tolkoff-Rubin, N Ginns, LC Wain, JC Preffer, F Olszak, I Wee, S Delmonico, FL Pascual, M
Citation: H. Vallhonrat et al., In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients, TRANSPLANT, 67(2), 1999, pp. 253-258
Human ovarian cancer cells from ascites express the human type II MIS receptor, bind labeled recombinant MIS and are growth inhibited
Authors: Masiakos, P MacLaughlin, D Teixeira, J Kehas, D Fuller, A Preffer, F Dombkowski, D Donahoe, P
Citation: P. Masiakos et al., Human ovarian cancer cells from ascites express the human type II MIS receptor, bind labeled recombinant MIS and are growth inhibited, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 257-261
Risultati: 1-7 |